mercoledì, 25 novembre 2020
Medinews
12 Marzo 2018

Prostate cancer medicine Radium-223 dichloride must not be used with Abiraterone acetate and prednisone/prednisolone

March 9, 2018 – The European Medicines Agency (EMA) has recommended contraindicating the use of the prostate cancer medicine Radium-223 dichloride with Abiraterone acetate and prednisone/prednisolone, due to an increased risk of death and fractures with this combination. EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) has reviewed the preliminary data from an ongoing clinical study in metastatic prostate cancer patients. In this study 34.7% … (leggi tutto)

TORNA INDIETRO